Influx Healthtech, the healthcare-focused SME, made a remarkable entry into the stock market by listing at ₹132.50 per share on the NSE Emerge platform on June 25. This marks an impressive 38% premium over its IPO price of ₹96.
What’s even more noteworthy is that the listing significantly outperformed grey market expectations. Before listing, unlisted shares of the company were trading at a 21% premium (around ₹116), but the actual debut surpassed these estimates by a wide margin.
Influx Healthtech’s IPO garnered massive interest from investors. During its three-day subscription period from June 18 to June 20, the issue was subscribed a massive 187.32 times, signaling strong trust and enthusiasm among market participants.
IPO Price: ₹96 per share
Listing Price: ₹132.50 per share
Listing Platform: NSE Emerge
Premium on Listing: 38%
Grey Market Premium Before Listing: 21%
IPO Subscription: 187.32 times
The strong debut showcases investor confidence in the company’s growth potential and highlights the increasing interest in quality SME listings in the Indian stock market.
Know more about us-
NiftyTrader
GiftNifty
IPO
Influx Healthtech
IndiGo Crisis Intensifies as Govt Steps In; DGCA Suspends FDTL Rules, Full Restoration Expected in…
Markets Cheer RBI’s Growth-Driven Rate Cut as Sensex Rises 447 Points and Nifty Ends Near…
RBI Cuts Repo Rate and Lifts Growth Forecast, Boosting Sentiment in Rate-Sensitive Stocks In a…
CAMS Shares Appear to Plunge 80% as 1:5 Stock Split Kicks In, but Investors Are…
Major Cloudflare Outage Ripples Across India’s Trading Platforms, Disrupting Market Activity A sudden Cloudflare outage…
IndiGo Shares Bounce Back as DGCA Offers Partial Relief on Pilot Duty Rules Amid Nationwide…
This website uses cookies.